Analysis of exon 1 mutations in the androgen receptor gene

Human Mutation

Volumn 14, Issue 6, 1999, Pages 527-539

  Gottlieb, Bruce ^a,c   Vasiliou, Denise M ^a,b   Lumbroso, Rose ^a   Beitel, Lenore K ^a   Pinsky, Leonard ^a,b   Trifiro, Mark A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c JOHN ABBOTT COLLEGE   (Canada)

Author keywords

AIS; Androgen insensitivity syndrome; Androgen receptor; AR

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; DNA; RNA;

ANDROGEN INSENSITIVITY SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FRAMESHIFT MUTATION; GENE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOP CODON;

ANDROGEN-INSENSITIVITY SYNDROME; ANIMALS; BASE SEQUENCE; CODON, NONSENSE; CODON, TERMINATOR; COS CELLS; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; EXONS; FEMALE; FRAMESHIFT MUTATION; HUMANS; KINETICS; MALE; MUTAGENESIS, SITE-DIRECTED; MUTATION; MUTATION, MISSENSE; PHENOTYPE; POINT MUTATION; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

EID: 0032794411     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-1004(199912)14:6<527::AID-HUMU12>3.0.CO;2-X     Document Type: Article

References (48)

1. Auseubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. 1994. Current protocols in molecular biology, vol 2. Toronto: John Wiley & Sons, p 10.2.1-10.2.6; 10.8.1-10.8.3.
2. Batch JA, Williams DM, Davies HR, Brown BD, Evans BAJ, Hughes IA, Patterson MN. 1992. Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet 1:497-503.
3. Beitel LK, Kazemi-Esfarjani P, Trifiro MA, Kaufman M, Lumbroso R, DiOeorge AM, Killinger D, Pinsky L. 1994. Substitution of arginine 839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance. J Clin Invest 94:546-554.
4. Beitel LK, Lumbroso R, Panet-Raymond V, Beauchemin A, Pinsky L, Trifiro MA. 1998. Androgen receptor-interacting proteins isolated using the expanded polyglutamine region implicated in the pathogenesis of spinobulbar muscular atrophy as bait. Program 80th Endocrine Soc Meeting Abstr No: OR 34-4.
5. Chamberlain NL, Whitacre DC, Miesfeld RL. 1996. Delineation of two distinct type I activation functions in the androgen receptor amino-terminal domain. J Biol Chem 271:26772-26778.
6. Chang C, Kokontis J, Liao S. 1988. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Nad Acad Sci USA 85:7211-7215.
7. Chen W, Kubota S, Teramoto T, Nishimura Y, Yonemoto K, Seyama Y. 1998. Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5′ splice site in the mutant codon in cerebrotendinous xanthomatosis patients. Biochemistry 37:4420-4428.
8. Deana A, Erlich R, Reiss C. 1998. Silent mutations in Escherichia coli OmpA leader peptide region strongly affect transcription and translation in vivo. Nucleic Acids Res 26:4778-4782.
9. Du YZ, Dickerson C, Aylsworth AS, Schwart CE. 1998. A silent mutation C924T (G308O) in the L1CAM gene results in X linked hydrocephalus (HSAS). J Med Genet 35:456-462.
10. Gao TS, Brantley K, Bolu E, McPhaul MJ. 1998. Proteins that interact with the amino terminus of the human androgen receptor (AR) exert major effects on AR function in eukaryotic cells. Program 80th Endocrine Soc Abstr No: OR48-1.
11. Gilliland G, Perrin S, Bunn FF. 1990. Competitive PCR for quantitation of mRNA. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego: Academic Press, p 60-69.
12. Gottlieb B, Lehvaslaiho H, Beitel LK, Lumbroso R, Pinsky L, Trifiro M. 1998. The androgen receptor gene mutations database. Nucleic Acids Res 26:234-238.
13. Greenberg CR, Hamerton JL, Nigili M, Wrogemann K. 1987. DNA studies in a family with Duchenne muscular dystrophy and a deletion at Xp21. Am J Hum Genet 41:128-137.
14. Higuchi R. 1990. Recombinant PCR. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego: Academic Press. p 177-183.
15. Hiort O, Klauber G, Cendron M, Sinnecker GHG, Keim L, Schwinger E, Wolfe HJ, Yandell DW. 1994. Molecular characterization of the androgen receptor gene in boys with hypospadias. Eur J Pediatr 153:317-321.
16. Hiort O, Holterhus P-M, Schultze W, Horter T, Sinnecker GHG. 1998. Androgen insensitivity in infertile males - endocrine and molecular genetic abnormalities. Program 80th Endocrine Soc Meeting Abstr 2-38.
17. Holterhus P-M, Bruggenwirth HT, Hiort O, Kleinkauf-Houcken A, Kruse K, Sinnecker GHG, Brinkmann AO. 1997. Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome. J Clin Endocrinol Metab 82:3584-3589.
18. Jenster G, van der Korput HA, van Vroonhoven C, van der Kwast TH, Trapman J, Brinkmann AO. 1991. Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 5:1396-1404.
19. Jenster G, van der Korput HA, van Vroonhoven C, Trapman J, Brinkmann AO. 1995. Identification of two transcription activation units in the N-terminal domain of the androgen receptor amino-terminal domain. J Biol Chem 271:7341-7346.
20. Kallio PJ, Palvimo JJ, Mehto M, Janne OA. 1994. Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. J Biol Chem 269:11514-11522.
21. Kaufman M, Straisfeld C, Pinsky L. 1979. Specific 5α-dihydrotestosterone binding in labial skin fibroblasts cultured from patients with male pseudohermaphroditism. Clin Genet 9:567-574.
22. Kazemi-Esfarjani P, Beitel LK, Trifiro M, Kaufman M, Rennie P, Sheppard P, Matusik R, Pinsky L. 1993. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively, with distinct androgen receptor phenotypes. Mol Endocrinol 7:37-46.
23. Kollmus H, Flohe L, McCarthy JE. 1996. Analysis of eukaryotic mRNA structures directing cotranslational incorporation of selenocysteine. Nucleic Acids Res 24:1195-1201.
24. Koshy B, Manila T, Burright EN, Merry DE, Fischbeck KH, Orr HT, Zoghbi HY. 1996. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum Mol Genet 5:1311-1318.
25. Langley E, Zhou Z, Wilson EM. 1995. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270:29983-29990.
26. Langridge J, Langridge P, Bergquist PL. 1980. Extraction of nucleic acids from agarose gels. Anal Biochem 103:264-271.
27. Liu W, Oian C, Francke U. 1997. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome. Nat Genet 16:328-329.
28. Lu J, Danielson M. 1996. A Stu 1 polymorphism in the human androgen receptor gene (AR). Clin Genet 49:323-324.
29. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM. 1988. The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2:1265-1275.
30. Macke JP, Hu N, Hu S, Bailey M, King VL, Brown T, Hamer D, Nathans J. 1993. Sequence variation in the androgen receptor gene is not a common determinant of male sexual orientation. Am J Hum Genet 53:844-852.
31. MacLean HE, Warne GL, Zajac JD. 1997. Localization of the functional domains in the androgen receptor. J Steroid Biochem Mol Biol 62:233-242.
32. McEwan IJ, Gustafsson JA. 1997. Interaction of the human androgen transactivation function with the general transcription factor TFIIF. Proc Nad Acad Sci USA 94:8485-8490.
33. McIntosh I, Hamosh A, Dietz HC. 1993. Nonsense mutations and diminished mRNA levels. Nat Genet 4:219.
34. Nordenskjöld A, Friedman E, Tapper-Persson M, Söderhäll C, Leviav A, Svensson J, Anvert M. 1999. Screening for mutations in candidate genes for hypospadias. Urol Res 27:49-55.
35. Palvimo JJ, Reinikainen P, Ikonen T, Kallio PJ, Moilanen A, Jänne OA. 1996. Mutual transcriptional interference between RelA and androgen receptor. J Biol Chem 271:24151-24156.
36. Pinsky L, Kaufman M, Levitsky LL. 1987. Partial androgen resistance due to a distinctive qualitative defect of the androgen receptor. Am J Med Genet 27:459-466.
37. Prior L, Bordet S, Trifiro MA, Mhatre A, Kaufman M, Pinsky L, Wrogeman K, Belsham DD, Pereira F, Greenberg C, Trapman J, Brinkmann AO, Chang C, Liao S. 1992. Replacement of arginine 773 by cysteine and histidine in the human androgen receptor causes complete androgen insensitivity with different receptor phenotypes. Am J Hum Genet 51:143-166.
38. Rodien P, Mebarki F, Mowszowicz I, Chaussain J-L, Young J, Morel Y, Schaison G. 1996. Different phenotypes in a family with androgen insensitivity caused by the same M780I point mutation in the androgen receptor gene. J Clin Endocrinol Metab 81:2994-2998.
39. Sai T, Seino S, Chang C, Trifiro M, Pinsky L, Mhatre A, Kaufman M, Lambert B, Trapman J, Brinkmann AO, Rosenfield RL, Liao S. 1990. An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity. Am J Hum Genet 46:1095-1100.
40. Sambrook J, Fritsch EF, Maniatis T. 1989. Commonly used techniques in molecular cloning: purification of nucleic acids. In: Molecular cloning, a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, p E3-E4.
41. Shkolny DL, Brown TR, Punnett HH, Kaufman M, Trifiro MA, Pinsky L. 1995. Characterization of alternative amino acid substitutions at arginine 830 of the androgen receptor that cause complete androgen insensitivity in three families. Hum Mol Genet 4:515-521.
42. Simental JA, Sar M, Lane MV, French FS, Wilson EM. 1991. Transcriptional activation and nuclear targeting signals of the human androgen receptor. J Biol Chem 266:510-518.
43. Tate WP, Poole ES, Horsfield JA, Mannering SA, Brown CM, Moffat JG, Dalphin ME, McCaughan KK, Major LL, Wilson DN. 1995. Translational termination efficiency in both bacteria and mammals as regulated by the base following the stop codon. Biochem Cell Biol 73:1095-1103.
44. Tate WP Mannering SA. 1996. Three, four or more: the translational stop signal at length. Mol Microbiol 21:213-219.
45. Trifiro M, Gottlieb B, Pinsky L, Kaufman M, Prior L, Belsham DD, Wrogemann K, Brown CJ, Willard HF, Trapman J, Brinkmann AO, Chang C, Liao S, Sergovich F, Jung J. 1991. The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor gene. Mol Cell Endocrinol 75:37-47.
46. Vasiliou M, Trifiro M, Pinsky L. 1994. Mutations in the N-terminal domain of the human androgen receptor associated with androgen resistance syndrome. Program 76th Endocrine Soc Meeting Abstr 1179.
47. Wang Q, Ohadessy FJ, Yong EL. 1998. Analysis of the transactivation domain of the androgen receptor in patients with male infertility. Clin Genet 54:185-192.
48. Zegers ND, Claassen E, Neelen C, Mulder E, van Laar JH, Voorhorst MM, Berrevoets CA, Brinkmann AO, van der Kwast, Ruizeveld JA, Trapman J, Boersma WJA. 1991. Epitope prediction and the confirmation for the human androgen receptor: generation of monoclonal antibodies for multi-assay performance following the synthetic peptide strategy. Biochem Biophys Acta 1073:23-32.